Skip to main content
ABION Inc. logo

ABION Inc. — Investor Relations & Filings

Ticker · 203400 ISIN · KR7203400007 KO Professional, scientific and technical activities
Open in API
Filings indexed 408 across all filing types
Latest filing 2025-04-25 Major Shareholding Noti…
Country KR South Korea
Listing KO 203400

About ABION Inc.

https://abionbio.com/en/

ABION Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative medicines, focusing on first-in-class and best-in-class therapeutics for oncology and viral diseases. The company's lead oncology asset is ABN401, a selective c-Met tyrosine kinase inhibitor (TKI) designed to treat non-small cell lung cancer (NSCLC) with MET mutations, which has shown a favorable safety profile. Another key pipeline candidate is ABN501, a novel monoclonal antibody targeting Claudin-3 for various cancers. Beyond oncology, ABION is developing ABN101, a second-generation Interferon-β formulated as a broad-spectrum anti-viral inhaler for respiratory infections. The company aims to commercialize its assets in global markets through internationally recognized clinical processes.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and contractual relationships (such as collateral agreements) of major shareholders and their special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-04-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and contractual relationships (such as collateral agreements) of major shareholders and special related parties of the company 'Abion Inc.' (에이비온 주식회사). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-04-11 Korean
타법인주식및출자증권처분결정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (Abion) announcing the decision to dispose of shares in another corporation (Vivozon). It details the number of shares, the disposal amount, the purpose (securing operating funds), and the board resolution date. This type of disclosure regarding the sale of assets or equity in other companies is classified as a regulatory filing under the RNS category as it does not fit into specific categories like M&A (which usually implies a merger or acquisition of a business entity) or share buybacks (which refers to the company's own shares).
2025-04-04 Korean
합병등종료보고서(자산양수도)
M&A Activity Classification · 100% confidence The document is a 'Report on the Completion of Merger, etc.' (합병등종료보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the completion of an asset transfer (disposal of shares in Vivozon) that was previously announced in a major report. Since this document confirms the finalization of a corporate transaction (M&A/Asset disposal) rather than an initial proposal or a general regulatory announcement, it falls under the M&A Activity category.
2025-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, dividend resolutions, and the election of directors and auditors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment or dismissal of outside directors ('사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고'). This falls under the category of board and management changes, which is classified as MANG.
2025-03-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.